United States Biotechnology & Medical Research

Uniqure NV (QURE)

Uniqure NV experienced a single insider transaction over the past ninety days, involving a proposed sale by Director David D. Meek. This activity follows a period of significant stock price decline. The company's most recent earnings report indicated a slight miss on earnings per share expectations.
Ticker: QURE Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Uniqure NV. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.6
Meek David D. Director Non-Executive Director
Transaction date
Proposed sale
Price
343.68
Quantity 8,528
Value US$2,433,133
2.7
Kapusta Matthew C CEO, Managing Director Executive Director
Transaction date
Planned sale
Price
493.44
Quantity 84,162 -28.9%
Value US$295,283
2.7
Kapusta Matthew C CEO, Managing Director Executive Director
Transaction date
Planned sale
Price
169.88
Quantity 27,407 -34.9%
Value US$2,393,095
2.7
Kapusta Matthew C CEO, Managing Director Executive Director
Transaction date
Planned sale
Price
44.43
Quantity 9,200 -1.7%
Value US$408,756
2.7
Kapusta Matthew C Officer; Director; CEO AND MANAGING DIRECTOR Executive Director
Transaction date
Proposed sale
Price
45.15
Quantity 21,082
Value US$951,932
2.3
Abi-Saab Walid Chief Medical Officer Officer
Transaction date
Planned sale
Price
46.40
Quantity 20,000 -11.9%
Value US$928,000
2.3
Abi-Saab Walid Chief Medical Officer Officer
Transaction date
Planned sale
Price
46.46
Quantity 10,000 -5.6%
Value US$464,600
2.4
Kaye Jack Non-Executive Director
Transaction date
Planned sale
Price
46.43
Quantity 17,060 -39.6%
Value US$792,096
2.4
Kaye Jack Non-Executive Director
Transaction date
Planned sale
Price
46.49
Quantity 4,107 -13.6%
Value US$190,934
2.3
Abi-Saab Walid Chief Medical Officer Officer
Transaction date
Proposed sale
Price
46.42
Quantity 30,000
Value US$1,392,643
2.4
Kaye Jack Director Non-Executive Director
Transaction date
Proposed sale
Price
46.44
Quantity 21,167
Value US$983,033
2.3
Abi-Saab Walid Chief Medical Officer Officer
Transaction date
Sale
Price
46.86
Quantity 1,434 -0.8%
Value US$67,197
2.3
Abi-Saab Walid Chief Medical Officer Officer
Transaction date
Proposed sale
Price
46.86
Quantity 1,434
Value US$67,197
2.7
Kapusta Matthew C CEO, Managing Director Executive Director
Transaction date
Planned sale
Price
50.02
Quantity 28,716 -5.2%
Value US$1,436,374
2.7
Kapusta Matthew C Officer; Director; CEO AND MANAGING DIRECTOR Executive Director
Transaction date
Proposed sale
Price
50.02
Quantity 28,716
Value US$1,436,305
2.7
Kapusta Matthew C CEO, Managing Director Executive Director
Transaction date
Planned sale
Price
50.00
Quantity 6,696 -1.3%
Value US$334,800
2.7
Kapusta Matthew C Officer; Director; CEO AND MANAGING DIRECTOR Executive Director
Transaction date
Proposed sale
Price
50.00
Quantity 6,696
Value US$334,800
2.7
Kapusta Matthew C CEO, Managing Director Executive Director
Transaction date
Planned sale
Price
50.00
Quantity 37,015 -6.6%
Value US$1,850,750
2.7
Kapusta Matthew C CEO, Managing Director Executive Director
Transaction date
Planned sale
Price
50.00
Quantity 37,015 -6.6%
Value US$1,850,750
2.7
Kapusta Matthew C CEO, Managing Director Executive Director
Transaction date
Planned sale
Price
50.00
Quantity 4,656 -0.8%
Value US$232,800
2.7
Kapusta Matthew C CEO, Managing Director Executive Director
Transaction date
Planned sale
Price
50.00
Quantity 4,656 -0.8%
Value US$232,800
2.7
Kapusta Matthew C Officer; Director; CEO AND MANAGING DIRECTOR Executive Director
Transaction date
Proposed sale
Price
46.38
Quantity 41,671
Value US$1,932,516
2.3
Balachandran Madhavan Non-Executive Director
Transaction date
Planned sale
Price
42.60
Quantity 1,690 -3.8%
Value US$71,994
2.3
Balachandran Madhavan Non-Executive Director
Transaction date
Planned sale
Price
42.60
Quantity 1,690 -3.8%
Value US$71,994
2.3
Balachandran Madhavan Non-Executive Director
Transaction date
Planned sale
Price
43.66
Quantity 4,700 -9.5%
Value US$205,202
2.3
Balachandran Madhavan Non-Executive Director
Transaction date
Planned sale
Price
43.66
Quantity 4,700 -9.5%
Value US$205,202
2.3
Balachandran Madhavan Non-Executive Director
Transaction date
Planned sale
Price
47.08
Quantity 5,295 -9.6%
Value US$249,289
2.3
Balachandran Madhavan Non-Executive Director
Transaction date
Planned sale
Price
47.08
Quantity 5,295 -9.6%
Value US$249,289
2.7
Kapusta Matthew C CEO, Managing Director Executive Director
Transaction date
Planned sale
Price
48.65
Quantity 11,585 -2.0%
Value US$563,610
2.7
Kapusta Matthew C CEO, Managing Director Executive Director
Transaction date
Planned sale
Price
48.65
Quantity 11,585 -2.0%
Value US$563,610
2.7
Kapusta Matthew C CEO, Managing Director Executive Director
Transaction date
Planned sale
Price
45.01
Quantity 33,334 -5.5%
Value US$1,500,363
2.7
Kapusta Matthew C CEO, Managing Director Executive Director
Transaction date
Planned sale
Price
45.01
Quantity 33,334 -5.5%
Value US$1,500,363
2.7
Kapusta Matthew C CEO, Managing Director Executive Director
Transaction date
Planned sale
Price
43.43
Quantity 56,929 -8.6%
Value US$2,472,426
2.7
Kapusta Matthew C CEO, Managing Director Executive Director
Transaction date
Planned sale
Price
43.43
Quantity 56,929 -8.6%
Value US$2,472,426
2.7
Kapusta Matthew C CEO, Managing Director Executive Director
Transaction date
Planned sale
Price
45.02
Quantity 32,581 -4.7%
Value US$1,466,797
2.7
Kapusta Matthew C CEO, Managing Director Executive Director
Transaction date
Planned sale
Price
45.02
Quantity 32,581 -4.7%
Value US$1,466,797
2.7
Kapusta Matthew C CEO, Managing Director Executive Director
Transaction date
Planned sale
Price
43.70
Quantity 6,023 -0.9%
Value US$263,205
2.7
Kapusta Matthew C CEO, Managing Director Executive Director
Transaction date
Planned sale
Price
43.70
Quantity 6,023 -0.9%
Value US$263,205
2.7
Kapusta Matthew C CEO, Managing Director Executive Director
Transaction date
Planned sale
Price
42.61
Quantity 23,977 -3.3%
Value US$1,021,660
2.4
Kaye Jack Non-Executive Director
Transaction date
Planned sale
Price
42.57
Quantity 5,295 -16.9%
Value US$225,408
2.4
Kaye Jack Non-Executive Director
Transaction date
Planned sale
Price
42.57
Quantity 5,295 -16.9%
Value US$225,408
2.7
Kapusta Matthew C Officer; Director; CEO AND MANAGING DIRECTOR Executive Director
Transaction date
Proposed sale
Price
43.00
Quantity 164,429
Value US$7,070,447
2.4
Kaye Jack Director Non-Executive Director
Transaction date
Proposed sale
Price
42.57
Quantity 5,295
Value US$225,393
2.3
Balachandran Madhavan Director Non-Executive Director
Transaction date
Proposed sale
Price
45.05
Quantity 11,685
Value US$526,463
2.3
Balachandran Madhavan Non-Executive Director
Transaction date
Planned sale
Price
27.85
Quantity 10,000 -18.8%
Value US$278,500
1.9
Potts Jeannette Chief Legal Officer Officer
Transaction date
Sale
Price
27.67
Quantity 5,237 -3.8%
Value US$144,908
1.9
Potts Jeannette Officer; CHIEF LEGAL OFFICER Officer
Transaction date
Proposed sale
Price
27.67
Quantity 5,237
Value US$144,886
2.6
Meek David D. Non-Executive Director
Transaction date
Sale
Price
27.06
Quantity 1,993 -4.8%
Value US$53,931
2.9
Gut Robert Non-Executive Director
Transaction date
Sale
Price
27.06
Quantity 2,726 -7.8%
Value US$73,766
1.4
O'Keefe Kylie Chief Customer & Strat Officer Officer
Transaction date
Sale
Price
27.06
Quantity 15,936 -12.8%
Value US$431,228
2.4
Springhorn Jeremy P. Non-Executive Director
Transaction date
Sale
Price
27.06
Quantity 1,993 -4.4%
Value US$53,931
2.3
POST LEONARD E Non-Executive Director
Transaction date
Sale
Price
27.06
Quantity 1,993 -5.3%
Value US$53,931
2.3
Balachandran Madhavan Non-Executive Director
Transaction date
Sale
Price
27.06
Quantity 1,993 -4.4%
Value US$53,931
2.4
Kaye Jack Non-Executive Director
Transaction date
Sale
Price
27.06
Quantity 1,993 -7.1%
Value US$53,931
2.3
Balachandran Madhavan Non-Executive Director
Transaction date
Sale
Price
27.06
Quantity 1,993 -4.4%
Value US$53,931
2.1
Jacques Rachelle Suzanne Director Non-Executive Director
Transaction date
Proposed sale
Price
27.06
Quantity 1,993
Value US$53,938
2.1
Jacques Rachelle Suzanne Director Non-Executive Director
Transaction date
Proposed sale
Price
27.06
Quantity 1,993
Value US$53,938
2.4
Springhorn Jeremy P. Director Non-Executive Director
Transaction date
Proposed sale
Price
27.06
Quantity 1,993
Value US$53,938
2.4
Springhorn Jeremy P. Director Non-Executive Director
Transaction date
Proposed sale
Price
27.06
Quantity 1,993
Value US$53,938
2.3
POST LEONARD E Director Non-Executive Director
Transaction date
Proposed sale
Price
27.06
Quantity 1,993
Value US$53,938
2.3
POST LEONARD E Director Non-Executive Director
Transaction date
Proposed sale
Price
27.06
Quantity 1,993
Value US$53,938
1.4
O'Keefe Kylie Officer; Chief Customer and Strategy Officer Officer
Transaction date
Proposed sale
Price
27.06
Quantity 15,936
Value US$431,290
1.4
O'Keefe Kylie Officer; Chief Customer and Strategy Officer Officer
Transaction date
Proposed sale
Price
27.06
Quantity 15,936
Value US$431,290
2.6
Meek David D. Director Non-Executive Director
Transaction date
Proposed sale
Price
27.06
Quantity 1,993
Value US$53,938
2.3
Balachandran Madhavan Director Non-Executive Director
Transaction date
Proposed sale
Price
27.06
Quantity 11,993
Value US$324,578
2.4
Kaye Jack Director Non-Executive Director
Transaction date
Proposed sale
Price
27.06
Quantity 1,993
Value US$53,938
2.9
Gut Robert Director Non-Executive Director
Transaction date
Proposed sale
Price
27.06
Quantity 2,726
Value US$73,776
2.9
Gut Robert Non-Executive Director
Transaction date
Planned sale
Price
26.05
Quantity 1,780 -6.1%
Value US$46,369
2.9
Gut Robert Non-Executive Director
Transaction date
Planned sale
Price
26.03
Quantity 3,127 -9.7%
Value US$81,396
2.9
Gut Robert Non-Executive Director
Transaction date
Planned sale
Price
26.07
Quantity 2,645 -7.6%
Value US$68,955
2.9
Gut Robert Director Non-Executive Director
Transaction date
Proposed sale
Price
26.05
Quantity 7,552
Value US$196,725
2.4
Kaye Jack Non-Executive Director
Transaction date
Planned sale
Price
30.01
Quantity 2,645 -11.5%
Value US$79,376
2.4
Kaye Jack Non-Executive Director
Transaction date
Planned sale
Price
30.01
Quantity 2,645 -11.5%
Value US$79,376
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-11-06 2026-11-06 PrS Proposed sale
2.6
Meek David D.

Director

Non-Executive Director
8,528
343.68
US$2,433,133 		8,528 343.68 US$2,433,133
2026-07-07 2026-07-02 PlS Planned sale
2.7
Kapusta Matthew C

CEO, Managing Director

Executive Director
84,162 -28.9%
493.44
US$295,283 		84,162 -28.9% 493.44 US$295,283
2026-07-07 2026-07-02 PlS Planned sale
2.7
Kapusta Matthew C

CEO, Managing Director

Executive Director
27,407 -34.9%
169.88
US$2,393,095 		27,407 -34.9% 169.88 US$2,393,095
2026-07-07 2026-07-02 PlS Planned sale
2.7
Kapusta Matthew C

CEO, Managing Director

Executive Director
9,200 -1.7%
44.43
US$408,756 		9,200 -1.7% 44.43 US$408,756
2026-07-02 2026-07-02 PrS Proposed sale
2.7
Kapusta Matthew C

Officer; Director; CEO AND MANAGING DIRECTOR

Executive Director
21,082
45.15
US$951,932 		21,082 45.15 US$951,932
2026-07-02 2026-06-30 PlS Planned sale
2.3
Abi-Saab Walid

Chief Medical Officer

Officer
20,000 -11.9%
46.40
US$928,000 		20,000 -11.9% 46.40 US$928,000
2026-07-02 2026-06-30 PlS Planned sale
2.3
Abi-Saab Walid

Chief Medical Officer

Officer
10,000 -5.6%
46.46
US$464,600 		10,000 -5.6% 46.46 US$464,600
2026-07-02 2026-06-30 PlS Planned sale
2.4
Kaye Jack
Non-Executive Director
17,060 -39.6%
46.43
US$792,096 		17,060 -39.6% 46.43 US$792,096
2026-07-02 2026-06-30 PlS Planned sale
2.4
Kaye Jack
Non-Executive Director
4,107 -13.6%
46.49
US$190,934 		4,107 -13.6% 46.49 US$190,934
2026-06-30 2026-06-30 PrS Proposed sale
2.3
Abi-Saab Walid

Chief Medical Officer

Officer
30,000
46.42
US$1,392,643 		30,000 46.42 US$1,392,643
2026-06-30 2026-06-30 PrS Proposed sale
2.4
Kaye Jack

Director

Non-Executive Director
21,167
46.44
US$983,033 		21,167 46.44 US$983,033
2026-06-30 2026-06-26 S Sale
2.3
Abi-Saab Walid

Chief Medical Officer

Officer
1,434 -0.8%
46.86
US$67,197 		1,434 -0.8% 46.86 US$67,197
2026-06-26 2026-06-26 PrS Proposed sale
2.3
Abi-Saab Walid

Chief Medical Officer

Officer
1,434
46.86
US$67,197 		1,434 46.86 US$67,197
2026-06-26 2026-06-25 PlS Planned sale
2.7
Kapusta Matthew C

CEO, Managing Director

Executive Director
28,716 -5.2%
50.02
US$1,436,374 		28,716 -5.2% 50.02 US$1,436,374
2026-06-25 2026-06-25 PrS Proposed sale
2.7
Kapusta Matthew C

Officer; Director; CEO AND MANAGING DIRECTOR

Executive Director
28,716
50.02
US$1,436,305 		28,716 50.02 US$1,436,305
2026-06-26 2026-06-24 PlS Planned sale
2.7
Kapusta Matthew C

CEO, Managing Director

Executive Director
6,696 -1.3%
50.00
US$334,800 		6,696 -1.3% 50.00 US$334,800
2026-06-24 2026-06-24 PrS Proposed sale
2.7
Kapusta Matthew C

Officer; Director; CEO AND MANAGING DIRECTOR

Executive Director
6,696
50.00
US$334,800 		6,696 50.00 US$334,800
2026-06-22 2026-06-18 PlS Planned sale
2.7
Kapusta Matthew C

CEO, Managing Director

Executive Director
37,015 -6.6%
50.00
US$1,850,750 		37,015 -6.6% 50.00 US$1,850,750
2026-06-22 2026-06-18 PlS Planned sale
2.7
Kapusta Matthew C

CEO, Managing Director

Executive Director
37,015 -6.6%
50.00
US$1,850,750 		37,015 -6.6% 50.00 US$1,850,750
2026-06-22 2026-06-18 PlS Planned sale
2.7
Kapusta Matthew C

CEO, Managing Director

Executive Director
4,656 -0.8%
50.00
US$232,800 		4,656 -0.8% 50.00 US$232,800
2026-06-22 2026-06-18 PlS Planned sale
2.7
Kapusta Matthew C

CEO, Managing Director

Executive Director
4,656 -0.8%
50.00
US$232,800 		4,656 -0.8% 50.00 US$232,800
2026-06-18 2026-06-18 PrS Proposed sale
2.7
Kapusta Matthew C

Officer; Director; CEO AND MANAGING DIRECTOR

Executive Director
41,671
46.38
US$1,932,516 		41,671 46.38 US$1,932,516
2026-06-22 2026-06-17 PlS Planned sale
2.3
Balachandran Madhavan
Non-Executive Director
1,690 -3.8%
42.60
US$71,994 		1,690 -3.8% 42.60 US$71,994
2026-06-22 2026-06-17 PlS Planned sale
2.3
Balachandran Madhavan
Non-Executive Director
1,690 -3.8%
42.60
US$71,994 		1,690 -3.8% 42.60 US$71,994
2026-06-22 2026-06-17 PlS Planned sale
2.3
Balachandran Madhavan
Non-Executive Director
4,700 -9.5%
43.66
US$205,202 		4,700 -9.5% 43.66 US$205,202
2026-06-22 2026-06-17 PlS Planned sale
2.3
Balachandran Madhavan
Non-Executive Director
4,700 -9.5%
43.66
US$205,202 		4,700 -9.5% 43.66 US$205,202
2026-06-22 2026-06-17 PlS Planned sale
2.3
Balachandran Madhavan
Non-Executive Director
5,295 -9.6%
47.08
US$249,289 		5,295 -9.6% 47.08 US$249,289
2026-06-22 2026-06-17 PlS Planned sale
2.3
Balachandran Madhavan
Non-Executive Director
5,295 -9.6%
47.08
US$249,289 		5,295 -9.6% 47.08 US$249,289
2026-06-22 2026-06-17 PlS Planned sale
2.7
Kapusta Matthew C

CEO, Managing Director

Executive Director
11,585 -2.0%
48.65
US$563,610 		11,585 -2.0% 48.65 US$563,610
2026-06-22 2026-06-17 PlS Planned sale
2.7
Kapusta Matthew C

CEO, Managing Director

Executive Director
11,585 -2.0%
48.65
US$563,610 		11,585 -2.0% 48.65 US$563,610
2026-06-22 2026-06-17 PlS Planned sale
2.7
Kapusta Matthew C

CEO, Managing Director

Executive Director
33,334 -5.5%
45.01
US$1,500,363 		33,334 -5.5% 45.01 US$1,500,363
2026-06-22 2026-06-17 PlS Planned sale
2.7
Kapusta Matthew C

CEO, Managing Director

Executive Director
33,334 -5.5%
45.01
US$1,500,363 		33,334 -5.5% 45.01 US$1,500,363
2026-06-22 2026-06-17 PlS Planned sale
2.7
Kapusta Matthew C

CEO, Managing Director

Executive Director
56,929 -8.6%
43.43
US$2,472,426 		56,929 -8.6% 43.43 US$2,472,426
2026-06-22 2026-06-17 PlS Planned sale
2.7
Kapusta Matthew C

CEO, Managing Director

Executive Director
56,929 -8.6%
43.43
US$2,472,426 		56,929 -8.6% 43.43 US$2,472,426
2026-06-22 2026-06-17 PlS Planned sale
2.7
Kapusta Matthew C

CEO, Managing Director

Executive Director
32,581 -4.7%
45.02
US$1,466,797 		32,581 -4.7% 45.02 US$1,466,797
2026-06-22 2026-06-17 PlS Planned sale
2.7
Kapusta Matthew C

CEO, Managing Director

Executive Director
32,581 -4.7%
45.02
US$1,466,797 		32,581 -4.7% 45.02 US$1,466,797
2026-06-22 2026-06-17 PlS Planned sale
2.7
Kapusta Matthew C

CEO, Managing Director

Executive Director
6,023 -0.9%
43.70
US$263,205 		6,023 -0.9% 43.70 US$263,205
2026-06-22 2026-06-17 PlS Planned sale
2.7
Kapusta Matthew C

CEO, Managing Director

Executive Director
6,023 -0.9%
43.70
US$263,205 		6,023 -0.9% 43.70 US$263,205
2026-06-22 2026-06-17 PlS Planned sale
2.7
Kapusta Matthew C

CEO, Managing Director

Executive Director
23,977 -3.3%
42.61
US$1,021,660 		23,977 -3.3% 42.61 US$1,021,660
2026-06-22 2026-06-17 PlS Planned sale
2.4
Kaye Jack
Non-Executive Director
5,295 -16.9%
42.57
US$225,408 		5,295 -16.9% 42.57 US$225,408
2026-06-22 2026-06-17 PlS Planned sale
2.4
Kaye Jack
Non-Executive Director
5,295 -16.9%
42.57
US$225,408 		5,295 -16.9% 42.57 US$225,408
2026-06-17 2026-06-17 PrS Proposed sale
2.7
Kapusta Matthew C

Officer; Director; CEO AND MANAGING DIRECTOR

Executive Director
164,429
43.00
US$7,070,447 		164,429 43.00 US$7,070,447
2026-06-17 2026-06-17 PrS Proposed sale
2.4
Kaye Jack

Director

Non-Executive Director
5,295
42.57
US$225,393 		5,295 42.57 US$225,393
2026-06-17 2026-06-17 PrS Proposed sale
2.3
Balachandran Madhavan

Director

Non-Executive Director
11,685
45.05
US$526,463 		11,685 45.05 US$526,463
2026-06-17 2026-06-15 PlS Planned sale
2.3
Balachandran Madhavan
Non-Executive Director
10,000 -18.8%
27.85
US$278,500 		10,000 -18.8% 27.85 US$278,500
2026-06-17 2026-06-15 S Sale
1.9
Potts Jeannette

Chief Legal Officer

Officer
5,237 -3.8%
27.67
US$144,908 		5,237 -3.8% 27.67 US$144,908
2026-06-15 2026-06-15 PrS Proposed sale
1.9
Potts Jeannette

Officer; CHIEF LEGAL OFFICER

Officer
5,237
27.67
US$144,886 		5,237 27.67 US$144,886
2026-06-12 2026-06-11 S Sale
2.6
Meek David D.
Non-Executive Director
1,993 -4.8%
27.06
US$53,931 		1,993 -4.8% 27.06 US$53,931
2026-06-12 2026-06-11 S Sale
2.9
Gut Robert
Non-Executive Director
2,726 -7.8%
27.06
US$73,766 		2,726 -7.8% 27.06 US$73,766
2026-06-12 2026-06-11 S Sale
1.4
O'Keefe Kylie

Chief Customer & Strat Officer

Officer
15,936 -12.8%
27.06
US$431,228 		15,936 -12.8% 27.06 US$431,228
2026-06-12 2026-06-11 S Sale
2.4
Springhorn Jeremy P.
Non-Executive Director
1,993 -4.4%
27.06
US$53,931 		1,993 -4.4% 27.06 US$53,931
2026-06-12 2026-06-11 S Sale
2.3
POST LEONARD E
Non-Executive Director
1,993 -5.3%
27.06
US$53,931 		1,993 -5.3% 27.06 US$53,931
2026-06-12 2026-06-11 S Sale
2.1
Jacques Rachelle Suzanne
Non-Executive Director
1,993 -5.6%
27.06
US$53,931 		1,993 -5.6% 27.06 US$53,931
2026-06-12 2026-06-11 S Sale
2.3
Balachandran Madhavan
Non-Executive Director
1,993 -4.4%
27.06
US$53,931 		1,993 -4.4% 27.06 US$53,931
2026-06-12 2026-06-11 S Sale
2.4
Kaye Jack
Non-Executive Director
1,993 -7.1%
27.06
US$53,931 		1,993 -7.1% 27.06 US$53,931
2026-06-12 2026-06-11 S Sale
2.1
Jacques Rachelle Suzanne
Non-Executive Director
1,993 -5.6%
27.06
US$53,931 		1,993 -5.6% 27.06 US$53,931
2026-06-12 2026-06-11 S Sale
2.3
Balachandran Madhavan
Non-Executive Director
1,993 -4.4%
27.06
US$53,931 		1,993 -4.4% 27.06 US$53,931
2026-06-11 2026-06-11 PrS Proposed sale
2.1
Jacques Rachelle Suzanne

Director

Non-Executive Director
1,993
27.06
US$53,938 		1,993 27.06 US$53,938
2026-06-11 2026-06-11 PrS Proposed sale
2.1
Jacques Rachelle Suzanne

Director

Non-Executive Director
1,993
27.06
US$53,938 		1,993 27.06 US$53,938
2026-06-11 2026-06-11 PrS Proposed sale
2.4
Springhorn Jeremy P.

Director

Non-Executive Director
1,993
27.06
US$53,938 		1,993 27.06 US$53,938
2026-06-11 2026-06-11 PrS Proposed sale
2.4
Springhorn Jeremy P.

Director

Non-Executive Director
1,993
27.06
US$53,938 		1,993 27.06 US$53,938
2026-06-11 2026-06-11 PrS Proposed sale
2.3
POST LEONARD E

Director

Non-Executive Director
1,993
27.06
US$53,938 		1,993 27.06 US$53,938
2026-06-11 2026-06-11 PrS Proposed sale
2.3
POST LEONARD E

Director

Non-Executive Director
1,993
27.06
US$53,938 		1,993 27.06 US$53,938
2026-06-11 2026-06-11 PrS Proposed sale
1.4
O'Keefe Kylie

Officer; Chief Customer and Strategy Officer

Officer
15,936
27.06
US$431,290 		15,936 27.06 US$431,290
2026-06-11 2026-06-11 PrS Proposed sale
1.4
O'Keefe Kylie

Officer; Chief Customer and Strategy Officer

Officer
15,936
27.06
US$431,290 		15,936 27.06 US$431,290
2026-06-11 2026-06-11 PrS Proposed sale
2.6
Meek David D.

Director

Non-Executive Director
1,993
27.06
US$53,938 		1,993 27.06 US$53,938
2026-06-11 2026-06-11 PrS Proposed sale
2.3
Balachandran Madhavan

Director

Non-Executive Director
11,993
27.06
US$324,578 		11,993 27.06 US$324,578
2026-06-11 2026-06-11 PrS Proposed sale
2.4
Kaye Jack

Director

Non-Executive Director
1,993
27.06
US$53,938 		1,993 27.06 US$53,938
2026-06-11 2026-06-11 PrS Proposed sale
2.9
Gut Robert

Director

Non-Executive Director
2,726
27.06
US$73,776 		2,726 27.06 US$73,776
2026-06-12 2026-06-10 PlS Planned sale
2.9
Gut Robert
Non-Executive Director
1,780 -6.1%
26.05
US$46,369 		1,780 -6.1% 26.05 US$46,369
2026-06-12 2026-06-10 PlS Planned sale
2.9
Gut Robert
Non-Executive Director
3,127 -9.7%
26.03
US$81,396 		3,127 -9.7% 26.03 US$81,396
2026-06-12 2026-06-10 PlS Planned sale
2.9
Gut Robert
Non-Executive Director
2,645 -7.6%
26.07
US$68,955 		2,645 -7.6% 26.07 US$68,955
2026-06-10 2026-06-10 PrS Proposed sale
2.9
Gut Robert

Director

Non-Executive Director
7,552
26.05
US$196,725 		7,552 26.05 US$196,725
2026-06-05 2026-06-03 PlS Planned sale
2.4
Kaye Jack
Non-Executive Director
2,645 -11.5%
30.01
US$79,376 		2,645 -11.5% 30.01 US$79,376
2026-06-05 2026-06-03 PlS Planned sale
2.4
Kaye Jack
Non-Executive Director
2,645 -11.5%
30.01
US$79,376 		2,645 -11.5% 30.01 US$79,376

See older Uniqure NV insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock Uniqure NV history with Plus

Billed monthly · Cancel anytime

Explore more

More insider trading research around Uniqure NV

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America